Consumer Defensive
Nature's Sunshine Products, Inc.(NATR)
Live Price
Offline$20.12
+0.20% today
1Y Change
+40.57%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $470.00M
- Revenue Growth
- +5.7%
- EPS Growth
- +163.4%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nature's Sunshine Products, Inc. (NATR) is a Consumer Defensive stock with a market cap of $470.00M and listed on NASDAQ. The stock last traded around $20.12 and up 40.6% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +5.7%, EPS growth of +163.4%, a dividend yield of 0.0%. What stands out right now is revenue +5.7%, EPS +163.4%, free cash flow +101.3% with operating margin 5.2% and ROIC 9.1%. Valuation is more restrained than many high-expectation growth names at P/E 23.9 and price/sales 1.0. Stock Foundry combines NATR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+5.7% vs +1.7% peer median
Operating Margin
Near sector median
+5.2% vs +6.6% peer median
P/E
Above sector median
23.9 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5.7% and EPS at +163.4%, with operating margin around 5.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +11.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +1.2% | -13.5% | -23.2% |
2026 Mar 10, 2026 | +62.2% | -1.3% | -4.3% | +5.3% |
2025 Nov 6, 2025 | +89.5% | +30.5% | +51.1% | +59.4% |
Benchmark Edge
NATR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NATR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NATR Max Drawdown
-29.21%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NATR and SPY.
Company Overview
Nature's Sunshine Products, Inc.
NASDAQ Capital Market
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
- Leadership
- Kenneth G. Romanzi
- IPO Date
- Jun 25, 2009
- Employees
- 819
- Street Address
- 2901 West Bluegrass Boulevard
- Mailing
- Lehi, UT, 84043
- Region
- Lehi, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 341 7900
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 23.9
- EV/EBITDA
- 10.2
- Price/Sales
- 1.0
- Price/Book
- 2.9
Growth
- Revenue
- +5.7%
- EPS
- +163.4%
- Free Cash Flow
- +101.3%
Profitability
- Gross Margin
- 69.5%
- Operating Margin
- 5.2%
- Net Margin
- 4.1%
- ROE
- 12.2%
- ROIC
- 9.1%
Balance Sheet
- Debt/Equity
- 0.12
- Current Ratio
- 2.28
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.